VRAX: Virax Biolabs Projected Price to Earnings

VRAX (Virax Biolabs Group) - company brandmark

Virax Biolabs Group efficiency relies on the sales of ViraxClear systems and the speed of adaptation to new viruses. Patents and government contracts create a significant barrier to entry for competitors. Fluctuations in the company's forward P/E, as shown in GURU.Markets, reflect market expectations, where the value of 0.00 expresses the metric level. Kit distribution is delegated to external factories through strict SLA agreements.

Market Cap to Projected Earnings: viraxbiolabs.com (VRAX) for 04/28/2023 - 11/16/2026

Analytical breakdowns and data insights for company Virax Biolabs (VRAX)

- stock value and consensus price forecast:
General company analysis:Virax Biolabs Corp
Signature product of viraxbiolabs.com

Professional managers utilize fundamental filters to determine the fair value of assets through the ratio of market capitalization to expected net profit. This metric measures the investment payback period, which is critical for Virax Biolabs Group (VRAX) when assessing the efficiency of production outsourcing and IT infrastructure, reflecting this in the company's forward P/E ratio.

Main competitors

Forward P/E Multiple A|DGX - Projected Price to Earnings Ratio|Illumina Inc - Projected Price to Earnings|exactsciences.com (EXAS) - Projected Price to Earnings Ratio|RVTY - Future Price to Earnings|Market Cap to Projected Earnings Bio-Rad Laboratories, Inc. BIO|NNNN: Forward P/E Multiple|SHC - Market Cap to Projected Earnings|Future Price to Earnings quidel.com|Projected Price to Earnings Ratio opko.com OPK|Forward P/E Multiple CDNA|Projected Price to Earnings Maravai LifeSciences Holdings, Inc. MRVI|Fulgent Genetics Inc - Projected Price to Earnings|Forward P/E Multiple Standard BioTools Corp LAB|CTKB: Projected Price to Earnings|OSUR - Forward P/E Multiple|XGN: Forward P/E Multiple|MDxHealth - Future Price to Earnings Multiple|LUCD (Lucid Diagnostics Inc.) - Forward P/E Multiple|PRE (Prenetics Global) - Market Cap to Future Earnings Ratio|Forward P/E Multiple IMDX|Market Cap to Future Earnings Ratio TRIB|Future Price to Earnings ProPhase Labs Inc PRPH|Market Cap to Projected Earnings Ainos Inc (AIMD)|CODX - Future Price to Earnings|Projected Price to Earnings Ratio Heart Test Labs|BMRA: Forward P/E Multiple|CDIO - Market Cap to Projected Earnings|Projected Price to Earnings ONCO|Bluejay Diagnostics, Inc. (BJDX) - Market Cap to Projected Earnings|Future Price to Earnings Aspira Women's Health (AWH)|AXDX (Accelerate Diagnostics, Inc) - Future Price to Earnings Multiple|CENTOGENE, N.V. - Projected Price to Earnings|Future Price to Earnings Multiple ENZ|Future Price to Earnings Multiple fresh2.co (FRES)|GENE (Genetic Technologies Limited) - Price to Future Earnings Ratio|ME: Forward P/E Multiple|Price to Future Earnings Ratio PMD